China post-marketing surveillance (PMS) study of Aldurazyme®

Trial Identifier: LPS16578
Sponsor: Genzyme, a Sanofi Company
Start Date: October 2021
Primary Completion Date: July 2023
Study Completion Date: July 2023
Condition: Metabolic Disorder

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Beijing, China, 100034
China Beijing, China, 100730
China Guangzhou, China, 510623
China Hangzhou, China, 310003
China Wuhan, China, 430030